Semaglutide's MASH Benefits Extend Beyond Weight Loss

(MedPage Today) — WASHINGTON — Semaglutide (Wegovy) improved hepatic inflammation and fibrosis in patients with metabolic dysfunction-associated steatohepatitis (MASH) through direct biological and weight loss-related effects, according to…